Nestlé/Pfizer: worth the price?
The price that Nestlé is paying for Pfizer’s infant nutrition business puts a high value on emerging markets. The Swiss foods group announced on Monday it would pay the American drugs company $11.85bn...
View ArticleIndia: pharma companies sales to suffer on new round of price controls
Just a few months ago, the Indian government announced that it would, by the end of the year, start implementing a $5bn plan to provide more than half the country’s 1.2bn people with free access to a...
View ArticleMexico rejects Nestlé-Pfizer deal
Mexico’s trust-busters are sometimes regarded as a rather toothless bunch. The concentration of markets as disparate as beer, television and telephony appears to prove the thesis. But the problem often...
View Article
More Pages to Explore .....